gp 100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+ T cells

British Journal of Cancer

Volumn 85, Issue 11, 2001, Pages 1738-1745

  Kierstead, L S ^a   Ranieri, E ^a   Olson, W ^a   Brusic, V ^b   Sidney, J ^c   Sette, A ^c   Kasamon, Y L ^a   Slingluff Jr, C L ^d   Kirkwood, J M ^a,e   Storkus, W J ^a,e  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b INSTITUTE FOR INFOCOMM RESEARCH   (Singapore)

^c Epimmune   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

^e UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

ELISPOT; gp 100 pmel17; Helper T cells; Melanoma; Tyrosinase; Vaccine

Indexed keywords

CANCER VACCINE; EPITOPE; GAMMA INTERFERON; GLYCOPROTEIN GP 100; HLA DR ANTIGEN; MONOPHENOL MONOOXYGENASE; HLA DR4 ANTIGEN; MELANOCYTE LINEAGE SPECIFIC ANTIGEN GP100; MELANOCYTE LINEAGE-SPECIFIC ANTIGEN GP100; MEMBRANE PROTEIN; OLIGOPEPTIDE; PMEL 17 PROTEIN; PROTEIN; TUMOR PROTEIN;

ADULT; AGED; ANTIGEN DETECTION; ANTIGEN RECOGNITION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EFFECTOR CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOASSAY; MALE; MELANOMA; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING; TH1 CELL; VACCINIA VIRUS; VIRUS RECOMBINANT; AMINO ACID SEQUENCE; CELL CULTURE; CELL LINE; CYTOLOGY; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; SEQUENCE HOMOLOGY; T LYMPHOCYTE; VIROLOGY;

ADULT; AMINO ACID SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; DENDRITIC CELLS; EPITOPES; FEMALE; HLA-DR4 ANTIGEN; HUMAN; MALE; MELANOMA; MEMBRANE GLYCOPROTEINS; MIDDLE AGE; MOLECULAR SEQUENCE DATA; MONOPHENOL MONOOXYGENASE; NEOPLASM PROTEINS; OLIGOPEPTIDES; PROTEIN BINDING; PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SUPPORT, U.S. GOV'T, P.H.S.; TH1 CELLS; TUMOR CELLS, CULTURED; VACCINIA VIRUS;

EID: 0035976313     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.2160     Document Type: Article

References (32)

1. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
2. Different cytokine profiles released by CD4+ and CD8+ tumor-draining lymph node cells involved in mediating tumor regression
3. Increase of HLA-DR4 in melanoma patients from Alabama
4. Differential requirement for CD4 help in the development of an antigen-specific CD8+ T cell response depending on the route of immunization
5. Melanoma vaccines
6. In vitro and in vivo induction of a Th cell response toward peptides of the melanoma-associated glycoprotein 100 protein selected by the TEPITOPE program
7. HLA DR4 is associated with the development of multiple basal cell carcinomas and malignant melanoma
8. Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules
9. Dendritic cells, interleukin 12, and CD4+ T lymphocytes in the initiation of class I-restricted reactivity to tumor/self peptide
10. Spontaneous regression of human melanoma/nonmelanoma skin cancer: Association with infiltrating CD4+ T cells
11. Quantification of CD8+ T lymphocytes responsive to human immunodeficiency virus (HIV) peptide antigens in HIV-infected patients and seronegative persons at high risk for recent HIV exposure
12. Neural network-based prediction of candidate T-cell epitopes
13. Strict peptide length is not required for the induction of cytotoxic T lymphocyte-mediated antiviral protection by peptide vaccination
14. The use of melanosomal proteins in the immunotherapy of melanoma
15. Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: Implications for tumor vaccine development
16. Differential role for IL-2 and IL-15 in the inhibition of apoptosis in short-term activated human lymphocytes
17. The role of interleukin-2, interleukin- 12, and dendritic cells in cancer therapy
18. CD4+ T cells are required to sustain CD8+ T-cell responses during chronic viral infection
19. HLA-DR4 antigen and lymph node metastases in poorly differentiated adenocarcinoma of the stomach
20. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors
21. Dendritic cell/peptide cancer vaccines: Clinical responsiveness and epitope spreading
22. Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo
23. An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins
24. Several common HLA-DR types share largely overlapping peptide binding repertoires
25. Melanoma antigens recognised by CD8+ and CD4+ T cells
26. The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor
27. Melanoma-specific CD4+ T cells recognize nonmuted HLA-DR-restricted tyrosinase epitopes
28. Identification of a MHC class II-restricted human gp 100 epitope using DR4-IE transgenic mice
29. Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: Enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-α
30. Detection of biotinylated cell surface receptors and MHC molecules in a capture ELISA: A rapid assay to measure endocytosis
31. Heterogeneity in antigen processing by different types of antigen-presenting cells. Effect of cell culture on antigen processing ability